PRSS35: A Drug Target / Disease Biomarker (G167681)

Target Name: PRSS35

NCBI ID: G167681

PRSS35

PRSS35: A Drug Target / Disease Biomarker

PRSS35 is a protein that is expressed in various tissues throughout the body. It is a key player in the regulation of cell growth and differentiation, and has been implicated in a number of diseases. In this article, we will explore the potential of PRSS35 as a drug target and biomarker.

The Protein Response to Stress (PRSS35) gene is located on chromosome 16 and encodes a protein that is involved in the regulation of cellular stress responses. The protein encoded by PRSS35 is a 21-kDa protein that is composed of 155 amino acid residues. PRSS35 is highly conserved, with only four% amino acid sequence identity between the encoded protein and known non-coding proteins.

PRSS35 is expressed in a wide range of tissues, including skeletal muscles, heart, brain, and organs. It is also expressed in various cell types, including neurons and glial cells. PRSS35 is involved in the regulation of cellular stress responses, and has been implicated in a number of diseases.

One of the key functions of PRSS35 is its role in the regulation of cell growth and differentiation. PRSS35 is involved in the regulation of cell proliferation, and is thought to play a negative role in the regulation of cell growth. This is evident from the fact that PRSS35 is highly expressed in tissues that require rapid cell growth, such as muscle and brain cells.

PRSS35 is also involved in the regulation of cell differentiation. It is a key player in the regulation of neural stem cell (NSC) self-renewal and proliferation, and is thought to play a role in the development and maintenance of neural stem cells. This is evident from the fact that PRSS35 is highly expressed in the brain, and is required for the survival and proliferation of NSC.

In addition to its role in cell growth and differentiation, PRSS35 is also involved in the regulation of cellular stress responses. It is a key player in the regulation of DNA damage repair, and is thought to play a role in the regulation of cellular stress responses. This is evident from the fact that PRSS35 is highly expressed in tissues that are exposed to cellular stress, such as muscle and heart cells.

PRSS35 is also involved in the regulation of cellular signaling pathways. It is a key player in the regulation of TGF-β signaling, and is thought to play a role in the regulation of cellular signaling pathways. This is evident from the fact that PRSS35 is highly expressed in tissues that are responsive to TGF-β signaling, such as cancer cells.

In conclusion, PRSS35 is a protein that is involved in the regulation of cell growth and differentiation, stress responses, and cellular signaling pathways. Its functions make it an attractive target for drug development, as it has the potential to be used for a variety of therapeutic applications. Further research is needed to fully understand the role of PRSS35 in disease and to develop effective treatments.

Protein Name: Serine Protease 35

The "PRSS35 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRSS35 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets